<optgroup id="umio8"></optgroup>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<code id="umio8"><xmp id="umio8"><code id="umio8"></code><optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<center id="umio8"><wbr id="umio8"></wbr></center>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><wbr id="umio8"></wbr></optgroup>
<center id="umio8"><wbr id="umio8"></wbr></center>

Media Release


WAYSHINE BIOPHARM ANNOUNCES WSD0922 RECEIVED FDA ODD R01 FUNDING SUPPORT CLINICAL DEVELOPMENT
October 14, 2021 Wayshine Biopharm, a clinical-stage pharmaceutical company, today announced that its First-in-Class CNS penetrab
Release time:2021-10-18
ORPHAN DRUG DESIGNATION GRANTED BY THE FDA FOR WSD0922
Wayshine Biopharm holding limited Announces ORPHAN DRUG DESIGNATION GRANTED By The FDA For WSD0922 IN GLIOMA (including GLIOBLASTOM
Release time:2019-07-26
April 12,2019 IND approval by FDA
Wayshine Biopharm has received IND approval from FDA about its innovative experimental medicine WSD0922, a First-in-Class CNS penetrable EGF
Release time:2019-04-16
Copyright ? 2018 Wayshine Biopharm International Ltd. Cayman
<optgroup id="umio8"></optgroup>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<code id="umio8"><xmp id="umio8"><code id="umio8"></code><optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"></center>
<center id="umio8"><wbr id="umio8"></wbr></center>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><div id="umio8"></div></optgroup>
<center id="umio8"><div id="umio8"></div></center>
<optgroup id="umio8"><wbr id="umio8"></wbr></optgroup>
<center id="umio8"><wbr id="umio8"></wbr></center>
国产色诱视频在线播放丝袜_性中国另类BBwBBw_亚洲AV片手机在线观看_国自产精品手机在线视频